Adoptive Immunotherapy for Hematological Malignancies Using T Cells Gene-Modified to Express Tumor Antigen-Specific Receptors
Accumulating clinical evidence suggests that adoptive T-cell immunotherapy could be a promising option for control of cancer; evident examples include the graft-vs-leukemia effect mediated by donor lymphocyte infusion (DLI) and therapeutic infusion of ex vivo-expanded tumor-infiltrating lymphocytes...
Saved in:
Main Author: | Hiroshi Fujiwara (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2014-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunotherapy in Pediatric Hematologic Malignant Neoplasms
by: Kyung Taek Hong
Published: (2020) -
Editorial: Immunotherapy for hematological malignancies in children
by: Yusi Zhou, et al.
Published: (2023) -
Chimeric Antigen Receptor-T-Cell Therapy for B-Cell Hematological Malignancies: An Update of the Pivotal Clinical Trial Data
by: Gils Roex, et al.
Published: (2020) -
The landscape overview of CD47-based immunotherapy for hematological malignancies
by: Hua Yang, et al.
Published: (2023) -
Genetic Variants as Targets for Immunotherapy of Hematological Tumors
Published: (2020)